Radiolabeling of statistically optimized nanosized atorvastatin suspension for liver targeting and extensive imaging of hepatocellular carcinoma | Carol Yousry

Radiolabeling of statistically optimized nanosized atorvastatin suspension for liver targeting and extensive imaging of hepatocellular carcinoma

Citation:: Yousry, C., N. S. Farrag, and A. M. Amin, "Radiolabeling of statistically optimized nanosized atorvastatin suspension for liver targeting and extensive imaging of hepatocellular carcinoma", Journal of drug delivery science and technology, vol. 80, pp. 104171, 2023.